[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100510211":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":57,"collaborators":59,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":25,"eligibilityCriteria":101,"healthyVolunteers":97,"sex":102,"minAge":103,"maxAge":25,"enrollmentInfo":104,"targetDuration":25,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Second Affiliated Hospital, Zhejiang University, School of Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Routine Angiography Follow-up (RAF) group","EXPERIMENTAL","Patients in the RAF group will have routine angiography follow-up at 12±3 months after revascularization.",[13],"Diagnostic Test: Routine Angiography Follow-up",{"label":15,"type":16,"description":17,"interventionNames":18},"Routine Clinical Follow-up (RCF) group","ACTIVE_COMPARATOR","Patients in the RCF group will have routine clinical follow-up at 12±3 months after revascularization, and the further interventions can be performed at the discretion of the physician according to the current standard.",[19],"Diagnostic Test: Routine Clinical Follow-up",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DIAGNOSTIC_TEST","Routine Angiography Follow-up",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Routine Clinical Follow-up",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Jun Jiang, MD, PhD","CONTACT","+86 0571 87784808","jiang-jun@zju.edu.cn",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Jinlong Zhang, MD, PhD","+86 15757197513","jinlong1102@zju.edu.cn",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"The Second Affiliated Hospital of Zhejiang University School of Medicine","RECRUITING","Hangzhou","Zhejiang","310009","China","CN",{"type":49,"coordinates":50},"Point",[51,52],120.16142,30.29365,{"lat":52,"lon":51},[55],{"name":56,"role":32,"phone":25,"phoneExt":25,"email":25},"Jun Jiang",{"type":58,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[60,62,64,66,68,70,72,74,77,80,82,85,87,89,91,93],{"name":61,"class":6},"Jinhua Central Hospital",{"name":63,"class":6},"Changxing People's Hospital",{"name":65,"class":6},"The Affiliated Hospital of Hangzhou Normal University",{"name":67,"class":6},"Second Affiliated Hospital of Shantou University Medical College",{"name":69,"class":6},"Dongyang People's Hospital",{"name":71,"class":6},"First Affiliated Hospital of Wenzhou Medical University",{"name":73,"class":6},"Huzhou Central Hospital",{"name":75,"class":76},"First Affiliated Hospital of Ningbo University","NETWORK",{"name":78,"class":79},"The First People's Hospital of Linping District","UNKNOWN",{"name":81,"class":79},"The Sixth People's Hospital of Xinjiang Uygur Autonomous Region",{"name":83,"class":84},"Ningbo Medical Center Lihuili Hospital","OTHER_GOV",{"name":86,"class":79},"The Eighth People's Hospital of JiNan",{"name":88,"class":6},"The First Affiliated Hospital of Nanchang University",{"name":90,"class":79},"Ruian People's Hospital of Zhejiang Province",{"name":92,"class":6},"Shaoxing Central Hospital",{"name":94,"class":79},"The Second People's Hospital of Quzhou","100510211","routine-angiography-follow-up-after-percutaneous-coronary-intervention-in-high-risk-patients-100510211",false,"NCT05923489","Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients","Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients (The REVISE Trial)","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Successful PCI with at least two of the following high-risk factors:\n\nA. Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main vessels (left anterior descending, left circumflex artery, right coronary artery); D. Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H. Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular filtration rate of \\\u003C30 ml per minute per 1.73 m2 of body-surface area or the receipt of dialysis); L. Myocardial infarction;\n\n\\- He\u002Fshe or his\u002Fher legally authorized representative provides written informed\n\nExclusion Criteria:\n\n* Revascularization with bare metal stents and\u002For balloon angioplasty with non-drug-coated balloons.\n* Pregnant and\u002For lactating women.\n* Life expectancy of less than 2 years.\n* Repeat interventional therapy is planned.\n* Subject was unable to provide written informed consent.","ALL","18 Years",{"count":105,"type":106},2618,"ESTIMATED","INTERVENTIONAL",[109],"NA","Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.",[112],"Coronary Artery Disease",[114],"percutaneous coronary intervention","2026-08-19",{"date":117,"type":118},"2026-08-21","ACTUAL",{"date":120,"type":118},"2023-10-26",{"date":122,"type":106},"2029-10-15",{"name":5,"class":6},1]